Correlation Between Kezar Life and Avenue Therapeutics

Can any of the company-specific risk be diversified away by investing in both Kezar Life and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kezar Life Sciences and Avenue Therapeutics, you can compare the effects of market volatilities on Kezar Life and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Avenue Therapeutics.

Diversification Opportunities for Kezar Life and Avenue Therapeutics

-0.46

Correlation Coefficient

Kezar Life  Avenue Therapeutics

Very good diversification

The 3 months correlation between Kezar and Avenue is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Kezar Life i.e., Kezar Life and Avenue Therapeutics go up and down completely randomly.

Pair Corralation between Kezar Life and Avenue Therapeutics

Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Avenue Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 2.19 times less risky than Avenue Therapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Avenue Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  190.00  in Avenue Therapeutics on September 17, 2024 and sell it today you would lose (10.00) from holding Avenue Therapeutics or give up 5.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Kezar Life Sciences  vs.  Avenue Therapeutics

Kezar Life Sciences

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.

Avenue Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avenue Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Kezar Life and Avenue Therapeutics

The main advantage of trading using opposite Kezar Life and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.

The idea behind Kezar Life Sciences and Avenue Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.